OrbiMed Capital GP VI LLC, 10% Owner at CTI BIOPHARMA CORP (CTIC), sold 2,000,000 shares at $3.50 ($7.0M) on 2021-01-07, disclosed to the SEC on 2021-01-11.
Open-market sale of $7.0M CTIC by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IRON | SELL | 2025-03-12 | $32.4M | — | Filing → |
| SCPH | BUY | 2024-08-15 | $2.0M | — | Filing → |
| NPCE | SELL | 2024-04-18 | $435K | — | Filing → |